The results showed rs1798802 (AA compared with GG: <i>P</i>=0.044, OR=0.72) and rs2293303 (TT compared with CC: <i>P</i>=0.002, OR=2.86; recessive model: <i>P</i>=0.006, OR=2.91; T compared with C: <i>P</i>=0.004, OR=1.19) polymorphisms were associated with overall cancer risk.
The results showed rs1798802 (AA compared with GG: <i>P</i>=0.044, OR=0.72) and rs2293303 (TT compared with CC: <i>P</i>=0.002, OR=2.86; recessive model: <i>P</i>=0.006, OR=2.91; T compared with C: <i>P</i>=0.004, OR=1.19) polymorphisms were associated with overall cancer risk.
The polymorphism rs4135385 of CTNNB1 genotype GA was associated with a higher risk for Stage III + IV HCC (modified Union for International Cancer Control) (P = 0.001, OR = 2.238).Genetic polymorphisms in the WNT2 and CTNNB1 genes were closely associated with HCC risk and progression in a Chinese Han population.